Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator)

被引:7
|
作者
Dugdale, Caitlin M. [1 ,2 ,3 ]
Rubins, David M. [3 ,4 ,6 ]
Lee, Hang [3 ,5 ]
McCluskey, Suzanne M. [1 ,2 ,3 ]
Ryan, Edward T. [1 ,3 ]
Kotton, Camille N. [1 ,3 ]
Hurtado, Rocio M. [1 ,3 ]
Ciaranello, Andrea L. [1 ,2 ,3 ]
Barshak, Miriam B. [1 ,3 ]
McEvoy, Dustin S. [6 ]
Nelson, Sandra B. [1 ,3 ]
Basgoz, Nesli [1 ,3 ]
Lazarus, Jacob E. [1 ,3 ]
Ivers, Louise C. [1 ,3 ,7 ]
Reedy, Jennifer L. [1 ,3 ]
Hysell, Kristen M. [1 ,3 ]
Lemieux, Jacob E. [1 ,3 ]
Heller, Howard M. [1 ,3 ]
Dutta, Sayon [3 ,6 ,8 ]
Albin, John S. [1 ,3 ]
Brown, Tyler S. [1 ,3 ,9 ]
Miller, Amy L. [4 ]
Calderwood, Stephen B. [1 ,3 ]
Walensky, Rochelle P. [1 ,2 ,3 ]
Zachary, Kimon C. [1 ,3 ,10 ]
Hooper, David C. [1 ,3 ,10 ]
Hyle, Emily P. [1 ,2 ,3 ]
Shenoy, Erica S. [1 ,3 ,10 ]
机构
[1] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA
[6] Massachusetts Gen Hosp, Mass Gen Brigham Clin Informat, Boston, MA 02114 USA
[7] Massachusetts Gen Hosp, Mass Gen Ctr Global Hlth, Boston, MA 02114 USA
[8] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
[9] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA USA
[10] Massachusetts Gen Hosp, Infect Control Unit, Boston, MA 02114 USA
关键词
COVID-19; diagnosis; electronic health record; diagnostic algorithm; clinical decision support system; PATIENT OUTCOMES; PRECAUTIONS; SYSTEMS;
D O I
10.1093/cid/ciab111
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Isolation of hospitalized persons under investigation (PUIs) for coronavirus disease 2019 (COVID-19) reduces nosocomial transmission risk. Efficient evaluation of PUIs is needed to preserve scarce healthcare resources. We describe the development, implementation, and outcomes of an inpatient diagnostic algorithm and clinical decision support system (CDSS) to evaluate PUIs. Methods. We conducted a pre-post study of CORAL (COvid Risk cALculator), a CDSS that guides frontline clinicians through a risk-stratified COVID-19 diagnostic workup, removes transmission-based precautions when workup is complete and negative, and triages complex cases to infectious diseases (ID) physician review. Before CORAL, ID physicians reviewed all PUI records to guide workup and precautions. After CORAL, frontline clinicians evaluated PUIs directly using CORAL. We compared pre- and post-CORAL frequency of repeated severe acute respiratory syndrome coronavirus 2 nucleic acid amplification tests (NAATs), time from NAAT result to PUI status discontinuation, total duration of PUI status, and ID physician work hours, using linear and logistic regression, adjusted for COVID-19 incidence. Results. Fewer PUIs underwent repeated testing after an initial negative NAAT after CORAL than before CORAL (54% vs 67%, respectively; adjusted odd ratio, 0.53 [95% confidence interval,.44-.63]; P < .01). CORAL significantly reduced average time to PUI status discontinuation (adjusted difference [standard error], -7.4 [0.8] hours per patient), total duration of PUI status (-19.5 [1.9] hours per patient), and average ID physician work-hours (-57.4 [2.0] hours per day) (all P < .01). No patients had a positive NAAT result within 7 days after discontinuation of precautions via CORAL. Conclusions. CORAL is an efficient and effective CDSS to guide frontline clinicians through the diagnostic evaluation of PUIs and safe discontinuation of precautions.
引用
收藏
页码:2248 / 2256
页数:9
相关论文
共 50 条
  • [21] The Pandemic of Coronavirus Disease 2019 (COVID-19)
    Rashid, Nurshamimi Nor
    [J]. CURRENT MOLECULAR MEDICINE, 2022, 22 (09) : 761 - 765
  • [22] Having Coronavirus Disease 2019 (COVID-19)
    Shapiro, Janet M.
    [J]. JAMA CARDIOLOGY, 2020, 5 (10) : 1091 - 1091
  • [23] The Coronavirus Disease 2019 (COVID-19) Pandemic
    Baloch, Saira
    Baloch, Mohsin Ali
    Zheng, Tianli
    Pei, Xiaofang
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 250 (04): : 271 - 278
  • [24] Clinical Consequences of COVID-19 Lockdown in Patients With COPD Results of a Pre-Post Study in Spain
    Gonzalez, Jessica
    Moncusi-Moix, Anna
    Benitez, Ivan D.
    Santisteve, Sally
    Monge, Aida
    Angeles Fontiveros, Maria
    Carmona, Paola
    Torres, Gerard
    Barbe, Ferran
    de Batlle, Jordi
    [J]. CHEST, 2021, 160 (01) : 135 - 138
  • [25] Ethnicity as a Risk Factor for the Novel Coronavirus Disease 2019 (COVID-19)
    Hamad, Abubaker M.
    Al-Mohammed, Hi
    Alkhorayee, Mohammed
    Abbas, Mohammed Y.
    Sulieman, Abdelmoneim
    [J]. JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2021, 9 (12): : 66 - 75
  • [26] Review of potential risk groups for coronavirus disease 2019 (COVID-19)
    Naveed, M.
    Naeem, M.
    Rahman, M. Ur
    Hilal, M. Gul
    Kakakhel, M. A.
    Ali, G.
    Hassan, A.
    [J]. NEW MICROBES AND NEW INFECTIONS, 2021, 41
  • [27] Generalizability of Coronavirus Disease 2019 (COVID-19) Clinical Prediction Models
    Hooli, Shubhada
    King, Carina
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) : 897 - 897
  • [28] Clinical characteristics of coronavirus disease 2019 (COVID-19) patients in Kuwait
    Alshukry, Abdullah
    Ali, Hamad
    Ali, Yaseen
    Al-Taweel, Talal
    Abu-Farha, Mohammad
    AbuBaker, Jehad
    Devarajan, Sriraman
    Dashti, Ali A.
    Bandar, Ali
    Taleb, Hessah
    Al Bader, Abdullah
    Aly, Nasser Y.
    Al-Ozairi, Ebaa
    Al-Mulla, Fahd
    Bu Abbas, Mohammad
    [J]. PLOS ONE, 2020, 15 (11):
  • [29] Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)
    Kordzadeh-Kermani, Elaheh
    Khalili, Hossein
    Karimzadeh, Iman
    [J]. FUTURE MICROBIOLOGY, 2020, 15 (13) : 1287 - 1305
  • [30] Coronavirus disease 2019 (COVID-19): research progress and clinical practice
    Kutsuna, Satoshi
    [J]. GLOBAL HEALTH & MEDICINE, 2020, 2 (02): : 78 - 88